Traitement symptomatique

Le traitement de la fièvre , si l’enfant est inconfortable, repose sur :

- le paracétamol p.os 15 mg/kg/dose chaque 4 à 6 heures


- l’ibuprofène p.os 10mg/kg/dose chaque 6 heures selon les nécessités.

Faire boire l’enfant.

1Krauss BS, Harakal T, Fleischer GR. The spectrum and frequency of illness presenting to a pediatric emergency department. Pediatr Emerg Care 1991; 7:67-71

2Slater M, Krug SE. Evaluation of the infant with fever without source: an evidence based approach. Emerg Med Clin N Amer 1999; 17:97-126

3Teele DW, Pelton SI, Grant MJA, et al. Bacteremia in febrile children under two years of age : Results of cultures of blood of 600 consecutive febrile children seen in a « walk-in » clinic. J Pediatr. 1975; 87:227-230

4Baraff LJ, Oslund S, Schriger DL, Stephen ML. Probability of bacterial infections in infants less than three months of age: a meta-analysis Pediatr Infect Dis J 1992; 11:257-265

5McCarthy PL, Sharpe MR, Spiesel et al. Observation scales to identify serious illness in febrile children. Pediatrics 1982;70:802-809.

6Jaffe DM, Fleisher GR. Temperature and total white blood cell counts as indicators of bacteremia. Pediatrics 1991; 87:670-674.

7Hamoudi AC, Bubis SC, Thompson C. Can the cost savings of eliminating urine microscopy in biochemically negative urines be extended to the pediatric population ? Am J Clin Pathol 1986; 86:658-660.

8 M Caflisch. La protéine C-réactive et l’état fébrile sans foyer chez l’enfant de moins de 24 mois. Med Hyg 2000;58:366-370.

9Galetto Lacour A, Zamora S A, Gervaix A. Bedside procalcitonin and C-reactive protein tests in children with fever without localizing signs of infection seen in a referral center. Pediatrics 2003; 112:1054.

10Van Rossum AMC, Wulkan RW, Oudesluys-Murphy AM. Procalcitonin as an early marker of infection in neonates and children. The Lancet infectious diseases 2004; 4:620-630.

11 Gervaix A. Valeurs et interprétations des marqueurs biologiques d’infection bactérienne aux urgences » dans « Fièvre et urgences» Editions Scientifiques L&C, Paris, 2006 chapitre 23, p 345-357

12Baraff LJ, Bass JW, Fleisher GR et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Pediatrics 1993; 82:1-12.

13Stoll ML, Rubin LG. Incidence of occult bacteremia among highly febrile joung children in the era of the pneumococcal conjugate vaccine: a study from a Children’s Hospital Emergency Department and Urgent Care Center. Arch Pediatr Adolesc Med 2004; 158(7):671-5.

14Herz AM, Greenhow TL, Alcantara J, Hansen J, Baxter RP, Black SB, Shinefield HR. Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine. Pediatr Infect Dis J 2006; 25(4):293-300.

15Galetto Lacour A, Gervaix A, Zamora SA, Vadas L, Lombard PR, Dayer JM, Suter S. Procalcitonin, IL-6, IL-8, IL-1 receptor antagonist and C-reactive protein as identificators of serious bacterial infections in children with fever without localising signs. Eur J of Ped 2001 ; 160(2) :95-100.